Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia

The Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) offer different recommendations for carbapenem MIC susceptibility breakpoints for Acinetobacter species. In addition, the clinical efficacy of the intermediate category...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Yang, Ya-Sung, Wang, Yung-Chih, Kuo, Shu-Chen, Chen, Chung-Ting, Liu, Chang-Pan, Liu, Yuag-Meng, Chen, Te-Li, Lee, Yi-Tzu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571357/
https://ncbi.nlm.nih.gov/pubmed/28652230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00661-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados